Pith. sign in

REVIEW 3 major objections 4 minor 49 references

Compensator-based small animal IMRT enables conformal preclinical dose painting: application to tumor hypoxia

T0 review · 3 major / 4 minor · reviewed 2026-08-10 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

Pith's one-line read Small-animal IMRT delivered by 3D-printed compensators significantly improves dose conformity and boost separation for oxygen-guided dose painting in mouse fibrosarcomas relative to conformal radiotherapy.

desk verdict Solid first real-data comparison of small-animal IMRT vs CRT for hypoxia dose painting; the headline gap is real but the CRT baseline is deliberately unoptimized and there's a CI/beam-angle contradiction that needs fixing. read the letter →

arxiv 2501.15684 v1 pith:5P5ISGSC submitted 2025-01-26 physics.med-ph

Jordan M. Slagowski , Erik Pearson , Rajit Tummala , Gage Redler , Daniela Olivera Velarde , Boris Epel , Howard J. Halpern , Bulent Aydogan This is my paper · ORCID
classification physics.med-ph
keywords smallanimalIMRTdosepaintingtumorhypoxiasimultaneousintegratedboostelectronparamagneticresonanceimaging3D-printedcompensatorconformalradiotherapytreatmentplanningcomparison
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper tries to establish that intensity-modulated radiotherapy can be scaled down to mice and that it delivers the same kind of dose-painting advantage seen in clinical treatments. In seventeen mice with leg fibrosarcomas, the authors compared inverse-planned, compensator-based small-animal IMRT against forward-planned three-dimensional conformal radiotherapy for boosting hypoxic tumor voxels identified by electron paramagnetic resonance imaging. For three-beam plans, SA-IMRT produced a median hypoxic conformity index of 0.45 versus 0.17 for CRT, improved tumor dose uniformity, and a median D50% dose difference of 13.1 Gy versus the ideal 13 Gy between the boost and the rest of the tumor, compared with 7.3 Gy for CRT. The paper also concludes that three uniformly spaced beam angles are enough, with no significant conformity gain from adding more. If true, the result matters because it gives preclinical radiobiology a delivery method that mimics clinical dose painting, making oxygen-guided hypotheses testable in mice before translation.

What carries the argument

The central object is a compensator-based small-animal IMRT platform: a 225 kVp image-guided irradiator whose beam is shaped by 3D-printed copper-doped PLA compensators, with thickness varying spatially across each beamlet to modulate fluence. The argument runs through an inverse treatment planning system with a pencil-beam dose engine commissioned against Monte Carlo calculations, and a weighted piecewise-quadratic objective function that penalizes deviations from 22.5 Gy in the tumor PTV, deviations from 35.5 Gy in the hypoxic target volume, dose outside a 0.9 mm ring around the hypoxic volume, and overdosage of the body. Solving that objective yields fluence patterns converted into printable compensator files, while the same platform with conformal apertures and uniform beam weights generates the CRT plans used for comparison. Plan quality is scored with the Paddick conformity index, D25% and D50% dose differences between hypoxic and non-hypoxic targets, and the ratio of standard deviation to mean dose in the PTV.

What would settle it

Recompute the same seventeen plans with the CRT apertures' beam weights optimized by the inverse objective instead of uniform weights; if median hypoxic conformity and D50% separation approach the IMRT values, the central advantage is an artifact of the forward-planned baseline.

Watch

Extended reading notes

Core claim

Using seventeen mice with fibrosarcoma tumors and EPRI-defined hypoxic volumes, this paper reports the first treatment-planning comparison of small-animal IMRT against conformal radiotherapy for oxygen-guided dose painting. Delivering 22.5 Gy to the whole tumor and a 13 Gy simultaneous integrated boost (35.5 Gy total) to hypoxic voxels, the authors found that inverse-planned, compensator-based IMRT was significantly more conformal (median hypoxic Paddick CI 0.45 vs 0.17 at 3 angles), more uniform within the PTV (σ/μ 11.0% vs 14.3%), and closer to the ideal 13 Gy separation between boost and non-boost target doses (median D50% difference 13.1 Gy vs 7.3 Gy). They further report that 3 uniformly spaced beam angles captured essentially all of the conformity benefit, with no significant improvement from more angles, and that plan quality declined as hypoxic-target surface-area-to-volume ratio and number of discrete hypoxic regions increased. The authors frame this as evidence that SA-IMRT can replicate the clinical dose-painting paradigm in preclinical models and support outcome studies of oxygen-guided radiation therapy.

Load-bearing premise

The load-bearing premise is that the conformal-radiotherapy baseline is the right comparator: because CRT beams were forward-planned with uniform weights, the size of the IMRT advantage depends on that baseline, and the authors note that optimized CRT weighting could change the results.

Editorial extensions

If this is right

  • Oxygen-guided dose painting in mice can now be delivered with a median 13.1 Gy separation between hypoxic boost and whole-tumor dose, essentially the ideal 13 Gy, whereas CRT reached only 7.3 Gy.
  • Three uniformly spaced beam angles capture the conformity benefit, so compensator fabrication time, filament use, and delivery time can be kept near the practical minimum.
  • Plan quality scales with hypoxic-target complexity: animals with few, compact hypoxic regions will benefit most, and the reported regression could pre-screen subjects for IMRT studies.
  • Future outcome studies can test whether a conformal hypoxic boost changes tumor control without the confounding large dose spill into normoxic tumor regions that limited earlier oxygen-guided trials.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • If the CRT baseline were optimized too, the reported advantage might shrink; the paper's own caveat that uniformly weighted CRT beams could change the results makes this the natural next calculation.
  • The conclusion that three beam angles suffice is tied to flank fibrosarcoma and hypoxia dose painting; uniformity kept improving with more angles, so other applications or target geometries may need more beams.
  • Since IMRT used a coarser 1.0 mm bixel grid than the CRT apertures (0.5 and 0.25 mm), the demonstrated gain came despite coarser modulation; testing finer bixels or regularized fluences could reveal whether the advantage can be pushed further.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

3 major / 4 minor

Summary. This manuscript presents the first treatment planning comparison between compensator-based small animal intensity modulated radiation therapy (SA-IMRT) and three-dimensional conformal radiotherapy (CRT) for dose painting of tumor hypoxia, using CT/EPRI data from seventeen mice with fibrosarcoma tumors. Plans were generated with 2, 3, 5, 7, 9, and 15 uniformly distributed beam angles; IMRT uses a piecewise-quadratic inverse optimizer (Eq. 2) while CRT is forward-planned with uniformly weighted conformal apertures. Plan quality is scored with the Paddick conformity index for the hypoxic target, PTV dose uniformity (σ/mean), and D25%/D50% differences between the hypoxic boost and the PTV. The headline result is that SA-IMRT significantly improves conformity (median hypoxic CI 0.45 vs 0.17), PTV uniformity (11.0% vs 14.3%), and dose separation (D50% difference 13.1 Gy vs 7.3 Gy) at 3 beam angles, and that no further D50% improvement is obtained beyond 3 angles.

Significance. If the reported results hold, the study is a useful quantitative step for preclinical radiotherapy: it uses realistic animal data, applies paired statistics with multiple-comparison correction, and builds on a previously validated beam model and delivery platform. The finding that IMRT can achieve near-ideal dose separation between hypoxic and normoxic targets, and the identification of 3 beams as a practical compromise, are of interest to the small-animal radiotherapy community. The paper is also transparent in stating several limitations, including the lack of per-plan delivery QA and the uniform distribution of beam angles. However, the central comparative claim rests on the fairness of the CRT baseline, and the manuscript contains internal inconsistencies that currently weaken the evidence.

major comments (3)
  1. [Section 2.C and Discussion] The IMRT-versus-CRT comparison is not yet a fair head-to-head. CRT plans were forward-planned with uniformly weighted beams and two conformal apertures per angle, while IMRT plans were produced by the inverse optimizer in Eq. (2), whose terms directly penalize deviation from the same 22.5/35.5 Gy targets and a ring structure used as evaluation endpoints. The authors state in the Discussion that "The results presented here may be altered if CRT beam angles were weighted differently/optimally." Given the size of the reported differences (median hypoxic CI 0.45 vs 0.17; D50% difference 13.1 vs 7.3 Gy), the claim that SA-IMRT "yields dose distributions that more closely mimic the clinical setting" needs a sensitivity analysis or an optimized-CRT replanning to establish the magnitude. Table 1 shows median PTV mean dose 32.9 Gy for CRT versus 28.2 Gy for IMRT, indicating that part of the D50% separation deficit reflects unoptimized PTV overdosing rather than an inability to shape the boost.
  2. [Abstract vs Section 4] The abstract states "No significant improvement in CI was associated with >3 beam angles (Wilcoxon signed-rank test, p < 0.05)", but the Discussion states "A significant improvement in CI_HTV was observed with use of 5, 7, and 9 beam angles relative to the 3-angle scenario (supplemental figure 2)." These statements are mutually contradictory. Section 3.C reports the no-significance result for D50% difference, not CI. Please correct the abstract or reconcile the statistical findings, since the optimal-number-of-beams sub-aim depends on this.
  3. [Section 3.D and Table 1] The text claims "significant improvements in PTV dose uniformity were observed for IMRT versus CRT plans for a fixed number of beam angles", but Table 1 reports a p-value of 3.0E-01 for PTV uniformity (σ/mean) at 3 angles, which is not significant. If the p-value belongs to a different column (e.g., PTV D95%), the table must be relabeled; if it is correct, the uniformity claim in the abstract and Section 3.D is unsupported. This also affects the abstract's statement of improved tumor dose uniformity (11.0% versus 14.3%).
minor comments (4)
  1. [Table 1] In the σ row, the CRT PTV mean-dose standard deviation is listed as 32.9 Gy, identical to the mean; this is presumably a typo and should be corrected.
  2. [Abstract] The phrase "No significant improvement in CI was associated with >3 beam angles (Wilcoxon signed-rank test, p < 0.05)" is confusing: a significant result would be indicated by p < 0.05, not the absence of significance. Please use p > 0.05 or rephrase.
  3. [Section 2.C] The sentence "Bixel widths of 0.5 mm and 0.25 mm at isocenter were used for the PTV and HTV fields, respectively, for the CRT technique" is unclear for a CRT technique that uses apertures; please clarify how bixel resolution enters the forward-planned CRT dose calculation.
  4. [Table 1] The p-value row does not clearly align with the six metric columns; please provide explicit column headers for the p-values or add a separate row per metric.

Circularity Check

0 steps flagged · score 2.0 of 10

No substantive circularity: the SA-IMRT vs CRT comparison rests on independent forward-planned CRT baselines and identical scoring metrics; only minor objective-metric overlap and self-cited prior system validation prevent a clean 0.

full rationale

The central derivation is a planning comparison, not a first-principles prediction. IMRT plans are produced by the inverse optimizer in Eq. 2, while CRT plans are forward-planned with uniformly weighted beams and two conformal aperture sets per angle and therefore do not use that objective. Both arms are evaluated with the same external metrics: Paddick CI, D25%/D50% differences, and PTV uniformity. Because the CRT arm is not fitted to Eq. 2, the reported IMRT advantage (median hypoxic CI 0.45 vs 0.17; D50% 13.1 vs 7.3 Gy) is not forced by construction. The main caveats are non-circular: the IMRT objectives and the evaluation metrics both target the same 22.5/35.5 Gy dose separation and ring conformity, so the absolute IMRT numbers partly restate the optimizer's goals; and in the Discussion the authors explicitly acknowledge that 'The results presented here may be altered if CRT beam angles were weighted differently/optimally,' which is a robustness limitation of the CRT baseline, not a circularity. Self-citations (e.g., Ref. 33) are used for prior beam-model commissioning and delivery QA and are not invoked to forbid alternatives or to define the central outcome. Overall, no derivation step reduces to its own input.

Assumptions & free parameters 4 free parameters · 4 assumptions · 0 invented entities

The planning comparison depends on hand-selected objective weights, margins, bixel sizes, and beam angle schemes rather than on fitted physical constants. No new physical entity is introduced; the compensator is a previously described engineering device. The dose calculation rests on prior commissioning, and the present paper adds a planning comparison under a specific, stated set of assumptions.

free parameters (4)
  • Objective function weights (Eq. 2) = PTV 0.4, HTV 0.45, ring 0.10, body 1.0
    Chosen by the authors and fixed for all plans; the reported IMRT plan quality metrics (CI, D50 difference, uniformity) are direct products of these weights. No sensitivity analysis is included.
  • Ring expansion and block margins = 0.9 mm
    The ring planning structure expands the HTV by 0.9 mm within the PTV, and CRT apertures use a 0.9 mm block margin; these choices affect dose conformity and falloff.
  • Bixel resolution = 1.0 mm for IMRT; 0.5 mm and 0.25 mm for CRT
    Selected for computational tractability; the resolution difference could affect plan quality and the comparison.
  • Beam angle sets = 2, 3, 5, 7, 9, and 15 uniformly spaced angles over 360 degrees
    Beam count and spacing are design choices, not optimized; the '3 angles are sufficient' conclusion is specific to this arrangement and tumor model.
assumptions (4)
  • domain assumption The MatRad pencil-beam dose calculation, commissioned with EBT3 film and Monte Carlo, accurately predicts dose for compensator-modulated 225 kVp beams.
    Section 2.A relies on this for all computed doses; the present study does not repeat delivery QA, though prior work (Ref. 33) reported gamma pass rates.
  • domain assumption Hypoxic target volume is defined by pO2 <= 10 mmHg from EPRI.
    Section 2.B; the geometry of the HTV drives the dosimetric results and the target-complexity analysis.
  • ad hoc to paper The objective weights and normalization (D95% of HTV equals 35.5 Gy) produce clinically meaningful plans.
    Section 2.C; these choices are not derived from a biological model or a prior optimization.
  • standard math Paired two-sided Wilcoxon signed-rank tests with Bonferroni correction are appropriate for comparing plan metrics.
    Section 2.D; a standard nonparametric approach for paired, non-normal data.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Compensator-based small animal IMRT enables conformal preclinical dose painting: application to tumor hypoxia." pith.science (2026). https://pith.science/paper/5P5ISGSC

@misc{pith2026250115684,
  author       = {Pith},
  title        = {Pith review of: Compensator-based small animal IMRT enables conformal preclinical dose painting: application to tumor hypoxia},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/5P5ISGSC}},
  note         = {Machine review of arXiv:2501.15684}
}
read the original abstract

Techniques for preclinical intensity modulated radiation therapy are being developed to improve translation by replicating the clinical paradigm. This study presents the first treatment planning comparison between small animal IMRT (SA-IMRT) and three-dimensional conformal radiotherapy (CRT) in a model application, oxygen-guided dose painting of tumor hypoxia, using actual mouse data. A novel compensator-based platform was employed to generate SA-IMRT and CRT plans with 2-15 beam angles for seventeen mice with fibrosarcoma tumors. The whole tumor received a dose of 22.5 Gy, with a simultaneous integrated boost of 13 Gy to hypoxic voxels identified via electron paramagnetic resonance imaging. Plan quality was assessed using the Paddick conformity index (CI), uniformity, and dose volume histograms. For 3-angles, SA-IMRT yielded significantly improved dose conformity (median hypoxic CI =0.45 versus 0.17), tumor dose uniformity (11.0% versus 14.3%), and dosimetric spread between boost and non-boost targets (D50% difference = 13.0 Gy [ideal], 13.1 Gy [SA-IMRT], 7. 3 Gy [CRT]). No significant improvement in CI was associated with >3 beam angles (Wilcoxon signed-rank test, p < 0.05). This study demonstrates that SA-IMRT provides significant improvements in radiation plan quality and yields dose distributions that more closely mimic the clinical setting relative to current CRT approaches.

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

49 extracted references · 45 canonical work pages

  1. [1]

    Department of Human Oncology, University of Wisconsin-Madison, Madison WI, USA

    work page

  2. [2]

    Department of Radiation and Cellular Oncology, The University of Chicago, Chicago IL, USA

    work page

  3. [3]

    Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA *Corresponding author. E-mail address: slagowski@wisc.edu ABSTRACT: Techniques for preclinical intensity modulated radiation therapy are being developed to improve translation by replicating the clinical paradigm. This study presents the first treatment planning comparison between sma...

    work page

  4. [4]

    INTRODUCTION Tumor hypoxia is a source of radiation resistance and an eventual cause of treatment failure that has been known for more than a century.1–6 Oxygen-guided dose painting, defined as the administration of a locally increased prescription dose (i.e. boost) to a hypoxic tumor sub-volume defined by a tumor oxygen threshold, or a prescription dose ...

    work page

  5. [5]

    MATERIALS AND METHODS 2.A. SA-IMRT platform The system for SA-IMRT developed by our group is shown in Figure 1 and consists of an Xrad225Cx conformal irradiator with onboard cone beam CT (Precision X-ray, North Branford, CT), an inverse treatment planning system (TPS), 3D printed animal-specific compensators for radiation beam intensity modulation, and a ...

    work page

  6. [6]

    Dose painting tumor hypoxia Figure 2 presents IMRT and CRT dose distributions and differences for two example plans

    RESULTS 3.A. Dose painting tumor hypoxia Figure 2 presents IMRT and CRT dose distributions and differences for two example plans. Qualitatively, improved dose conformity and reduced dose spillage around the HTV is observed for IMRT versus CRT. A greater separation of the high dose volume prescribed to the HTV (35.5 Gy) versus the lower dose prescribed to ...

    work page

  7. [7]

    DISCUSSION The primary aim of this work was to investigate the dosimetric consequences of applying SA- IMRT for radiation dose painting in a preclinical setting using a novel compensator-based delivery system. While several methods and systems to perform intensity modulated radiotherapy for small animal subjects have recently been proposed, no systematic ...

    work page

  8. [8]

    However, a large spread in 𝐶𝐼𝐻𝑇𝑉, visualized in terms of the interquartile range, and Table 1 values is apparent

    These results demonstrate that SA-IMRT could be deployed to better differentiate dose levels to multiple target volumes as is required for dose painting tumor hypoxia. However, a large spread in 𝐶𝐼𝐻𝑇𝑉, visualized in terms of the interquartile range, and Table 1 values is apparent. This suggests some distributions of hypoxia may be well suited for IMRT tre...

    work page

Show all 49 references
  1. [9]

    CONCLUSION: Recent advancements have been made in the development of preclinical irradiation methodologies, including IMRT, that more closely mimic clinical techniques aimed at improving the translation of preclinical results to clinical outcomes. This study investigated the d...

  2. [10]

    Uber Desensibilisierung gegen Rontgen-und Radiumstrahlen

    Schwarz G. Uber Desensibilisierung gegen Rontgen-und Radiumstrahlen. Munchner Medizinische Wochenschrift. 1909;56:1217-1218

    1909

  3. [11]

    The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy

    Thomlinson RH, Gray LH. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy. Br J Cancer. 1955;9(4):539-549

    1955

  4. [12]

    Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix

    Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56(19):4509- 4515

    1996

  5. [13]

    Tumor hypoxia in pelvic recurrences of cervical cancer

    Höckel M, Schlenger K, Höckel S, Aral B, Schäffer U, Vaupel P. Tumor hypoxia in pelvic recurrences of cervical cancer. Int J Cancer. 1998;79(4):365-369. doi:10.1002/(sici)1097- 0215(19980821)79:4<365:aid-ijc10>3.0.co;2-4

    1998 doi

  6. [14]

    Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix

    Höckel M, Knoop C, Schlenger K, et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology. 1993;26(1):45-50. doi:10.1016/0167-8140(93)90025-4

    1993 doi

  7. [15]

    A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy

    Bouleftour W, Rowinski E, Louati S, et al. A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy. Med Sci Monit. 2021;27:e934116. doi:10.12659/MSM.934116

    2021 doi

  8. [16]

    Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality

    Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys. 2000;47(3):551-560. doi:10.1016/s0360-3016(00)00467-3

    2000 doi

  9. [17]

    Theragnostic imaging for radiation oncology: dose-painting by numbers

    Bentzen SM. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol. 2005;6(2):112-117. doi:10.1016/S1470-2045(05)01737-7 13

    2005 doi

  10. [18]

    Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription

    Bentzen SM, Gregoire V. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Semin Radiat Oncol. 2011;21(2):101-110. doi:10.1016/j.semradonc.2010.10.001

    2011 doi

  11. [19]

    Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images

    Cooper LAD, Kong J, Gutman DA, Dunn WD, Nalisnik M, Brat DJ. Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images. Lab Invest. 2015;95(4):366-376. doi:10.1038/labinvest.2014.153

    2015 doi

  12. [20]

    Small animal radiotherapy research platforms

    Verhaegen F, Granton P, Tryggestad E. Small animal radiotherapy research platforms. Phys Med Biol. 2011;56(12):R55-83. doi:10.1088/0031-9155/56/12/R01

    2011 doi

  13. [21]

    Conventional in vivo irradiation procedures are insufficient to accurately determine tumor responses to non-uniform radiation fields

    Butterworth KT, Redmond KM, McMahon SJ, et al. Conventional in vivo irradiation procedures are insufficient to accurately determine tumor responses to non-uniform radiation fields. Int J Radiat Biol. 2015;91(3):257-261. doi:10.3109/09553002.2014.980468

    2015

  14. [22]

    Advances in Preclinical Research Models of Radiation-Induced Cardiac Toxicity

    Schlaak RA, SenthilKumar G, Boerma M, Bergom C. Advances in Preclinical Research Models of Radiation-Induced Cardiac Toxicity. Cancers (Basel). 2020;12(2):415. doi:10.3390/cancers12020415

    2020 doi

  15. [23]

    Partial volume rat lung irradiation; assessment of early DNA damage in different lung regions and effect of radical scavengers

    Khan MA, Van Dyk J, Yeung IWT, Hill RP. Partial volume rat lung irradiation; assessment of early DNA damage in different lung regions and effect of radical scavengers. Radiother Oncol. 2003;66(1):95-

    2003

  16. [24]

    Oxygen-Guided Radiation Therapy

    Epel B, Maggio MC, Barth ED, et al. Oxygen-Guided Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019;103(4):977-984. doi:10.1016/j.ijrobp.2018.10.041

    2019 doi

  17. [25]

    Partial volume rat lung irradiation: An evaluation of early DNA damage

    Khan MA, Hill RP, Dyk JV. Partial volume rat lung irradiation: An evaluation of early DNA damage. International Journal of Radiation Oncology, Biology, Physics. 1998;40(2):467-476. doi:10.1016/S0360-3016(97)00736-0

    1998 doi

  18. [26]

    Patient Derived Models to Study Head and Neck Cancer Radiation Response

    Cosper PF, Abel L, Lee YS, et al. Patient Derived Models to Study Head and Neck Cancer Radiation Response. Cancers. 2020;12(2). doi:10.3390/cancers12020419

    2020 doi

  19. [27]

    Translation of research evidence from animals to humans

    Hackam DG, Redelmeier DA. Translation of research evidence from animals to humans. JAMA. 2006;296(14):1731-1732. doi:10.1001/jama.296.14.1731

    2006 doi

  20. [28]

    Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials

    Coleman CN, Higgins GS, Brown JM, et al. Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials. Clin Cancer Res. 2016;22(13):3138-3147. doi:10.1158/1078- 0432.CCR-16-0069

    2016 doi

  21. [29]

    High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities

    Wong J, Armour E, Kazanzides P, et al. High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities. Int J Radiat Oncol Biol Phys. 2008;71(5):1591-1599. doi:10.1016/j.ijrobp.2008.04.025

    2008 doi

  22. [30]

    Integration of optical imaging with a small animal irradiator

    Weersink RA, Ansell S, Wang A, et al. Integration of optical imaging with a small animal irradiator. Med Phys. 2014;41(10):102701. doi:10.1118/1.4894730

    2014 doi

  23. [31]

    Biological validation of electron paramagnetic resonance (EPR) image oxygen thresholds in tissue

    Gertsenshteyn I, Giurcanu M, Vaupel P, Halpern H. Biological validation of electron paramagnetic resonance (EPR) image oxygen thresholds in tissue. J Physiol. 2021;599(6):1759-1767. doi:10.1113/JP278816

    2021 doi

  24. [32]

    In vivo pO2 imaging of tumors: Oxymetry with very low frequency Electron Paramagnetic Resonance

    Epel B, Halpern HJ. In vivo pO2 imaging of tumors: Oxymetry with very low frequency Electron Paramagnetic Resonance. Methods Enzymol. 2015;564:501-527. doi:10.1016/bs.mie.2015.08.017

    2015 doi

  25. [33]

    Electron Paramagnetic Resonance pO2 Image Tumor Oxygen-Guided Radiation Therapy Optimization

    Epel B, Maggio M, Pelizzari C, Halpern HJ. Electron Paramagnetic Resonance pO2 Image Tumor Oxygen-Guided Radiation Therapy Optimization. Adv Exp Med Biol. 2017;977:287-296. doi:10.1007/978-3-319-55231-6_39

    2017 doi

  26. [34]

    Development of the open-source dose calculation and optimization toolkit matRad

    Wieser HP, Cisternas E, Wahl N, et al. Development of the open-source dose calculation and optimization toolkit matRad. Med Phys. 2017;44(6):2556-2568. doi:10.1002/mp.12251

    2017 doi

  27. [35]

    Approaching oxygen-guided intensity- modulated radiation therapy

    Epel B, Redler G, Pelizzari C, Tormyshev VM, Halpern HJ. Approaching oxygen-guided intensity- modulated radiation therapy. Adv Exp Med Biol. 2016;876:185-193. doi:10.1007/978-1-4939-3023- 4_23

    2016 doi

  28. [36]

    Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models

    Gertsenshteyn I, Epel B, Giurcanu M, et al. Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models. Front Med (Lausanne). 2023;10:1269689. doi:10.3389/fmed.2023.1269689 14

    2023

  29. [37]

    Clement CH, Stewart FA, Akleyev AV, et al. ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context. Ann ICRP. 2012;41(1-2):1-322. doi:...

    2012 doi

  30. [38]

    Two-dimensional inverse planning and delivery with a preclinical image guided microirradiator

    Stewart JMP, Lindsay PE, Jaffray DA. Two-dimensional inverse planning and delivery with a preclinical image guided microirradiator. Med Phys. 2013;40(10):101709. doi:10.1118/1.4819935

    2013 doi

  31. [39]

    A Sparse Orthogonal Collimator for Small Animal Intensity Modulated Radiation Therapy Part I: Planning System Development and Commissioning

    Woods K, Nguyen D, Neph R, Ruan D, O’Connor D, Sheng K. A Sparse Orthogonal Collimator for Small Animal Intensity Modulated Radiation Therapy Part I: Planning System Development and Commissioning. Med Phys. 2019;46(12):5703-5713. doi:10.1002/mp.13872

    2019 doi

  32. [40]

    A sparse orthogonal collimator for small animal intensity- modulated radiation therapy

    Woods K, Neph R, Nguyen D, Sheng K. A sparse orthogonal collimator for small animal intensity- modulated radiation therapy. Part II: hardware development and commissioning. Medical Physics. 2019;46(12):5733-5747. doi:10.1002/mp.13870

    2019 doi

  33. [41]

    Open-source medical devices (OSMD) design of a small animal radiotherapy system

    Prajapati S, Mackie TR, Jeraj R. Open-source medical devices (OSMD) design of a small animal radiotherapy system. 489 012017. J Phys: Conf Ser. Published online 2014:489. doi:10.1088/1742- 6596/489/1/012017

    2014 doi

  34. [42]

    A method for generating intensity-modulated radiation therapy fields for small animal irradiators utilizing 3D-printed compensator molds

    Yoon SW, Kodra J, Miles DA, Kirsch DG, Oldham M. A method for generating intensity-modulated radiation therapy fields for small animal irradiators utilizing 3D-printed compensator molds. Med Phys. 2020;47(9):4363-4371. doi:10.1002/mp.14175

    2020 doi

  35. [43]

    SA-IMRT Using 3D-Printed Compensators

    Redler G, Pearson E, Liu X, et al. SA-IMRT Using 3D-Printed Compensators. Int J Radiat Oncol Biol Phys. 2021;110(2):551-565. doi:10.1016/j.ijrobp.2020.12.028

    2021 doi

  36. [45]

    Efficient photon beam dose calculations using DOSXYZnrc with BEAMnrc

    Kawrakow I, Walters BRB. Efficient photon beam dose calculations using DOSXYZnrc with BEAMnrc. Med Phys. 2006;33(8):3046-3056. doi:10.1118/1.2219778

    2006 doi

  37. [46]

    AAPM protocol for 40-300 kV x-ray beam dosimetry in radiotherapy and radiobiology

    Ma CM, Coffey CW, DeWerd LA, et al. AAPM protocol for 40-300 kV x-ray beam dosimetry in radiotherapy and radiobiology. Med Phys. 2001;28(6):868-893. doi:10.1118/1.1374247

    2001 doi

  38. [47]

    A simple scoring ratio to index the conformity of radiosurgical treatment plans

    Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg. 2000;93 Suppl 3:219-222. doi:10.3171/jns.2000.93.supplement

    doi

  39. [48]

    Fraction-variant beam orientation optimization for non-coplanar IMRT

    O’Connor D, Yu V, Nguyen D, Ruan D, Sheng K. Fraction-variant beam orientation optimization for non-coplanar IMRT. Phys Med Biol. 2018;63(4):045015. doi:10.1088/1361-6560/aaa94f

    2018 doi

  40. [49]

    Improving the efficiency of small animal 3D-printed compensator IMRT with beamlet intensity total variation regularization

    Liu X, Van Slyke AL, Pearson E, Shoniyozov K, Redler G, Wiersma RD. Improving the efficiency of small animal 3D-printed compensator IMRT with beamlet intensity total variation regularization. Medical Physics. 2022;49(8):5400-5408. doi:10.1002/mp.15764 ACKNOWLEDGMENTS: This wor...

    2022 doi

  41. [102]

    doi:10.1016/s0167-8140(02)00325-0

    doi

Pith tools

Reviewed August 10, 2026 · model on record in the stance chip above.